Variability of mammary carcinogenesis induction in female Sprague-Dawley and Wistar:Han rats: The effect of season and age

Physiological Research

Volumn 51, Issue 6, 2002, Pages 633-640

  Kubatka, P ^a   Ahlersova E ^a   Ahlers, I ^a   Bojkova B ^a   Kalicka K ^a   Adamekova E ^a   Markova M ^a   Chamilova M ^a   Cermakova M ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Critical periods; Mammary carcinogenesis; Rat strains; Seasons; Susceptibility

Indexed keywords

CARCINOGEN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; FEMALE; HORMONE DETERMINATION; IMMUNE SYSTEM; NONHUMAN; PERINATAL PERIOD; RAT; SEASON; WINTER;

AGE FACTORS; ANIMALS; CARCINOGENS; DISEASE SUSCEPTIBILITY; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SEASONS; SPECIES SPECIFICITY;

EID: 0036977891     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AHLERS I, SOLÁ P, BUREŠOVÁ A, AHLERSOVÁ E: Very low sensitivity of Wistar:Han female rats to chemocarcinogen in mammary carcinogenesis induction. Neoplasma 45: 373-376, 1998.
2. BARTSCH H, BARTSCH C: Effect of melatonin on experimental tumors under different photoperiods and times of administration. J Neural Transm 52: 269-279, 1981.
3. BARTSCH H, BARTSCH C, MECKE D, LIPPERT TH: Seasonality of pineal melatonin production in the rat: possible synchronization by the geomagnetic field. Chronobiol Int 11: 21-26, 1994.
4. BOJKOVÁ B, AHLERS I, KUBATKA P, MOCIKOVÁ K, MNÍCHOVÁ M, AHLERSOVÁ E: Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar:Han rats to mammary carcinogenesis induction. Neoplasma 47: 230-233, 2000.
5. COS S, SÁNCHEZ-BARCELÓ EJ: Melatonin and mammary pathological growth. Front Neuroendocrinol 21: 133-170, 2000.
6. FESTING MFW: Use of multistrain assay could improve the NTP carcinogenesis bioassay. Environm Persp 103: 44-52, 1995.
7. HALBERG F: Grundlagenforschung zur Ätiologie des Karzinoms. Ärztl Fortb 2: 67-77, 1964.
8. HARVELL DM, STRECKER TE, TOCHACEK M, XIE B, PENNINGTON KL, MCCOMB RD, ROY SK, SHULL JD: Rat strain-specific actions of beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97: 2779-2784, 2000.
9. HSU LC, KENNAN WS, SHEPEL LA, JACOB HJ, SZPIRER C, SZIPER J, LANDER ES, GOULD MN: Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res 54: 2765-2770, 1994.
10. HUGGINS C, GRAND LC, BRILLANTES FP: Critical significance of breast structure in the induction of mammary cancer in the rat. Proc Natl Acad Sci USA 45: 1294-13000, 1959.
11. ISAACS JT: Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46: 3958-3963, 1986.
12. KIRKHAM N, MACHIN D, COTTON D, PIKE JM: Seasonality and breast cancer. Eur Surg Oncol 11: 143-146, 1985.
13. KOTHARI LS, SHAH PN, MHATRE MC: Effect of continuous light on the incidence of 9,10-dimethyl-1,2-benz(a)anthracene induced mammary tumors in female Holtzman rats. Cancer Lett 16: 313-317, 1982.
14. LÖSCHER W, MEVISSEN M, LEHMACHER W, STAMM A: Tumor promotion in a breast cancer model by a exposure to a weak alternating magnetic field. Cancer Lett 71: 75-81, 1993.
15. LÖSCHER W, MEVISSEN M, HAUSSLER M: Seasonal influence on 7, 12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions. Pharmacol Toxicol 81: 265-270, 1997.
16. LU SJ, LAROYE G, ARCHER MC: Mammary tumor induction by N-methyl-N-nitrosourea in genetically resistant Copenhagen rats. Cancer Res 52: 5037-5041, 1992.
17. MASON BH, HOLDAWAY IM, MULLINS PR, KAY RG, SKINNER SJ: Seasonal variation in breast cancer detection: correlation with tumor progesterone receptor status. Breast Cancer Res Treat 5: 171-176, 1985.
18. MCCORMICK DL, ADAMOWSKI CB, FIKS A, MOON RC: Lifetime dose-response relationships for mammary tumor reduction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41: 1690-1694, 1981.
19. NELSON RJ, BLOOM MCJ: Photoperiodic effects on tumor development and immune function. J Biol Rhythms 9: 233-249, 1994.
20. REITER RJ: A review of neuroendocrine and neurochemical changes associated with static and extremely low frequency electromagnetic field exposure. Integr Physiol Behav Sci 28: 57-75, 1993.
21. RUSSO IH, RUSSO J: Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104: 938-967, 1996.
22. RUSSO J, WILGUS G, RUSSO IH: Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 96: 721-736, 1979.
23. SHEPEL LA, GOULD MN: The genetic compounds of susceptibility to breast cancer in the rat. Prog Exp Tumor Res 35: 158-169, 1999.
24. SHEPEL LA, LAN H, HAAG JD, BRASIC GM, GHEEN ME, SIMON JS, HOFF P, NEWTON MA, GOULD MN: Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics 149: 289-299, 1998.